Runben Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	129.41	243.83	368.21	206.19	39.53	31.12
Short-Term Investments	-	1,340	-	-	-	-
Trading Asset Securities	266.92	19	8.24	56.24	42.17	4.29
Cash & Short-Term Investments	396.33	1,603	376.45	262.43	81.7	35.41
Cash Growth	-28.20%	325.85%	43.45%	221.20%	130.74%	-
Accounts Receivable	15.78	4.82	1.19	2.34	2.78	3.33
Other Receivables	3.2	2.32	6	9.8	5.73	0
Receivables	18.98	7.14	7.2	12.15	8.51	3.33
Inventory	123.43	92.91	102.71	56.9	45.22	29.58
Other Current Assets	1,319	13.16	23.68	12.89	6.38	5.49
Total Current Assets	1,858	1,716	510.04	344.36	141.82	73.8
Property, Plant & Equipment	262.9	260.42	277.56	207.67	108.73	67.34
Other Intangible Assets	18.26	18.76	19.36	19.88	20.54	21.1
Long-Term Deferred Tax Assets	41.61	20.82	14.8	5.66	2.39	2.07
Long-Term Deferred Charges	1.3	1.41	-	-	-	-
Other Long-Term Assets	36.62	1.13	3.65	68.77	2.99	0.12
Total Assets	2,218	2,019	825.42	646.34	276.47	164.43
Accounts Payable	49.31	40.15	36.99	46.37	13.27	14.17
Accrued Expenses	12.98	26.21	24.43	11.41	5.98	4.14
Current Portion of Leases	1.35	1.95	2.51	2.4	-	-
Current Income Taxes Payable	33.94	15.47	18.28	5.29	0.63	0.7
Current Unearned Revenue	3.25	5.97	4.5	4.2	3.44	-
Other Current Liabilities	74.37	5.36	9.89	5.84	0.92	6.28
Total Current Liabilities	175.2	95.12	96.6	75.52	24.23	25.29
Long-Term Leases	1.76	2.04	5.39	7.91	-	-
Long-Term Unearned Revenue	0.01	0.01	0.27	1.13	2.05	1.78
Long-Term Deferred Tax Liabilities	0.34	0.44	0.57	0.14	0.05	-
Total Liabilities	177.32	97.61	102.83	84.69	26.33	27.07
Common Stock	404.59	404.59	343.9	343.9	103.07	60
Additional Paid-In Capital	1,015	1,015	102.59	101.69	117.28	6.67
Retained Earnings	621.4	502.12	276.09	116.05	29.79	70.69
Shareholders' Equity	2,041	1,921	722.59	561.65	250.14	137.36
Total Liabilities & Equity	2,218	2,019	825.42	646.34	276.47	164.43
Total Debt	3.11	4	7.91	10.31	-	-
Net Cash (Debt)	393.21	1,599	368.54	252.12	81.7	35.41
Net Cash Growth	-28.19%	333.90%	46.18%	208.59%	130.74%	-
Net Cash Per Share	0.98	4.53	1.08	0.75	0.27	0.69
Filing Date Shares Outstanding	404.59	404.59	404.59	343.9	305.52	50.96
Total Common Shares Outstanding	404.59	404.59	343.9	343.9	305.52	50.96
Working Capital	1,683	1,621	413.44	268.84	117.59	48.51
Book Value Per Share	5.04	4.75	2.10	1.63	0.82	2.70
Tangible Book Value	2,023	1,903	703.22	541.76	229.6	116.26
Tangible Book Value Per Share	5.00	4.70	2.04	1.58	0.75	2.28
Buildings	-	232.54	231.65	163.47	43.21	42.96
Machinery	-	87.77	79.06	57.22	29.25	26.43
Construction In Progress	-	1.82	5.76	7.17	59.01	13.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.